Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2426.88 (Glytoucan)

Id:c88e0e77-9b2e-5665-815e-a201aeedb074

Glytoucan:G77408FM

Results found

Linked to

	Label	Description
	2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G87358EW-GLYCOSEQ00115730 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G94763YB-GLYCOSEQ00063680 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G11249YX-GLYCOSEQ00136078 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2426.88 has canonical residue n-glycan a-l-fucp 54 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G79394LC-GLYCOSEQ00189514 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2426.88 has motif 3-Sialyl-LN (type 2) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2426.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G35452GG-GLYCOSEQ00160820 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2426.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000056 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G87192TH-GLYCOSEQ00123093 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G87358EW-GLYCOSEQ00115730 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G94763YB-GLYCOSEQ00063680 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G11249YX-GLYCOSEQ00136078 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 has canonical residue n-glycan a-l-fucp 54

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G79394LC-GLYCOSEQ00189514 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 has motif 3-Sialyl-LN (type 2)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G35452GG-GLYCOSEQ00160820 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000056 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2426.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G87192TH-GLYCOSEQ00123093 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.